Verofilcon A Toric Contact Lenses for Presbyopia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to assess the comfort of Total30 Multifocal Toric contact lenses for individuals with presbyopia, a condition affecting near vision, who have previously worn reusable toric lenses. It will evaluate whether users are willing to continue wearing these lenses after one month. Individuals who have worn reusable toric lenses in the past year without major discomfort and are willing to wear the trial lenses daily may be suitable candidates. The study will evaluate comfort and clear vision after lens use. As an unphased trial, it offers participants the chance to contribute to understanding the comfort and effectiveness of these lenses for presbyopia.
What prior data suggests that these contact lenses are safe for presbyopic adults?
In clinical studies, patients using TOTAL30 Multifocal Toric contact lenses have reported achieving 20/20 vision. These lenses incorporate Water Gradient technology, which maintains cleanliness and comfort throughout the month. This feature is crucial, as discomfort often leads people to discontinue wearing contact lenses, particularly those with presbyopia, a condition that impairs near vision.
The lenses aim to deliver clear vision and lasting comfort, essential for long-term use. Although specific side effects for TOTAL30 lenses are not detailed, their emphasis on comfort and clarity suggests they are generally well-received by users. Additionally, since these lenses are available for individuals with astigmatism and presbyopia, they are likely safe for use.12345Why are researchers excited about this trial?
Researchers are excited about Total30 Multifocal Toric contact lenses because they offer a new approach for presbyopic individuals who also need astigmatism correction. Unlike traditional multifocal or toric lenses that may not cater specifically to this combination of needs, these lenses are designed to be reusable and made from silicone hydrogel, which enhances comfort and oxygen permeability. This could mean clearer vision with fewer compromises, providing a more tailored solution for people dealing with both presbyopia and astigmatism.
What evidence suggests that Total30 Multi focal toric contact lenses are effective for presbyopia?
Studies have shown that TOTAL30 Multifocal Toric contact lenses provide clear 20/20 vision for those needing help with different distances. Designed for individuals with astigmatism (when the eye isn't perfectly round) and presbyopia (difficulty seeing things up close with age), these lenses use Water Gradient Technology to ensure comfort throughout the day. In clinical assessments, users rated their comfort nearly 8 out of 10, even after a month of use. This suggests the lenses effectively provide clear vision and maintain comfort over time.12367
Are You a Good Fit for This Trial?
This trial is for adults aged 40 or older who have presbyopia and astigmatism, currently wear reusable toric contact lenses without major discomfort, and can see well with correction. Participants must be willing to wear the study lenses daily for at least a month. Pregnant or breastfeeding individuals cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are refit into Total30 Multifocal Toric contact lenses and assess comfort and vision over one month
Follow-up
Participants are monitored for comfort and vision satisfaction after the treatment phase
What Are the Treatments Tested in This Trial?
Interventions
- Total30 Multi focal toric contact lenses
Trial Overview
The study tests if Total30 Multifocal Toric (MFT) contact lenses are comfortable and provide good vision after one month of use in people already used to wearing similar contacts. Comfort and vision will be measured through surveys during the trial.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
This will be a prospective study to understand if reusable silicone hydrogel toric CL wearers who are presbyopic can be successfully refit into Total30 MFT CLs
Find a Clinic Near You
Who Is Running the Clinical Trial?
Southern College of Optometry
Lead Sponsor
Citations
1.
finance.yahoo.com
finance.yahoo.com/news/alcon-launches-total30-multifocal-astigmatism-130300158.htmlAlcon Launches TOTAL30 Multifocal for Astigmatism, the ...
Presently, contact lens drop-out rate is four times higher in presbyopes versus wearers below age 40 due to comfort.4-6 Astigmatic presbyopic ...
2.
glance.eyesoneyecare.com
glance.eyesoneyecare.com/stories/2026-02-18/alcon-launches-total30-multifocal-for-astigmatism-toric-contact-lens/Alcon launches TOTAL30 Multifocal for Astigmatism toric ...
Designed for astigmatic presbyopes, the latest TOTAL30 is the only monthly MF toric lens featuring proprietary Water Gradient Technology.
Clinical Performance of Verofilcon A Toric Contact Lenses
Thus, the purpose of this work is to determine Total30 MFT overall comfort, vision, willingness to remain in CLs after the study, and ...
Alcon Launches TOTAL30 Multifocal for Astigmatism, the ...
In clinical assessments, patients wearing TOTAL30 Multifocal for Astigmatism reported clear 20/20 vision, offering seamless vision at all ...
TOTAL30 ® Multifocal for Astigmatism
*Toric contact lens wearers with presbyopia can wear Multifocal Toric lenses; hyperopic and myopic lens wearers with presbyopia can wear Multifocal lenses.
Alcon is introducing TOTAL30 Multifocal (MF) for Astigmatism ...
Designed with Water Gradient technology to help resist deposits and maintain comfort throughout the month, TOTAL30® lenses are made to support ...
Biofinity® toric multifocal
Biofinity® toric multifocal contact lenses from CooperVision deliver performance to contact lens wearers who are both astigmatic and presbyopic.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.